Vertex pharmaceuticals articles
-
Ardevora Asset Management LLP Has $11.54 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Ardevora Asset Management LLP reduced its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 48.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,349 shares of the pharmaceutical company’s stock after selling 26,300 shares during the quarter. Ardevora Asset Management […]
-
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medi
-
Alnylam Pharmaceuticals (ALNY) to Release Earnings on Thursday
Alnylam Pharmaceuticals (NASDAQ:ALNY) will be releasing earnings before the market opens on Thursday, May 2, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=319432)